HUMAN BIOMOLECULAR RESEARCH INST (EIN 911875177) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1997

Legal Domicile

Principal Officer

JOHN CASHMAN

Phone

8584589305

Tax Period

2024-07-01 to 2025-06-30

HUMAN BIOMOLECULAR RESEARCH INST, founded in 1997, is a micro nonprofit in the Science & Technology sector that reported $9K in total revenue in fiscal year 2024. Revenue fell 92% from the prior year — a significant decline worth monitoring. Expenses of $338K exceeded revenue, resulting in a 3732% operating deficit.

Mission

TO CONDUCT RESEARCH AND DO FUNDAMENTAL STUDIES DIRECTED AT AMELIORATING HUMAN DISEASES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $8,810

Program Service Revenue $0

Investment Income $10

Other Revenue $0

TOTAL REVENUE $8,820

Expense Breakdown

Grants Paid $0

Salaries & Benefits $156,215

Fundraising Expenses $0

Program Expenses $160,279

Other Expenses $181,807

TOTAL EXPENSES $338,022

Year-over-Year Comparison

	2024	2023	Change
Revenue	$8,820	$108,065	-0.9%
Expenses	$338,022	$597,898	-0.4%
Net Income	$-329,202	$-489,833	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JEFF CAVINS	Director	1.00	Director	$0	$0	$0
MARVIN CHENG	Director	1.00	Director	$0	$0	$0
RONALD J CHRISTOPHER	Director	1.00	Director	$0	$0	$0
RANDY C FRISCH	Director	1.00	Director	$0	$0	$0
JACK GAVIN	Director	1.00	Director	$0	$0	$0
JOHN CASHMAN	President	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$8,820	$338,022	$3,782,114	$-329,202
2024	$108,065	$597,898	$4,033,064	$-489,833
2023	$643,586	$747,140	$4,553,034	$-103,554
2022	$636,157	$838,843	$4,701,107	$-202,686
2021	$850,156	$1,036,674	$5,067,390	$-186,518
2020	$498,821	$839,941	$4,939,411	$-341,120
2019	$614,562	$847,552	$5,458,030	$-232,990

HUMAN BIOMOLECULAR RESEARCH INST